ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $505,705 | -64.8% | 28,173 | -31.6% | 0.01% | -78.3% |
| Q3 2021 | $1,437,000 | -3.2% | 41,200 | -23.8% | 0.02% | -17.9% |
| Q2 2021 | $1,484,000 | +627.5% | 54,057 | +644.5% | 0.03% | +600.0% |
| Q1 2021 | $204,000 | -77.9% | 7,261 | -79.6% | 0.00% | -84.6% |
| Q4 2020 | $923,000 | -43.9% | 35,557 | -46.6% | 0.03% | -68.3% |
| Q2 2020 | $1,646,000 | +1110.3% | 66,529 | +395.6% | 0.08% | +1266.7% |
| Q4 2019 | $136,000 | -68.2% | 13,423 | -51.6% | 0.01% | -57.1% |
| Q1 2018 | $428,000 | – | 27,723 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |